Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LeanDose vs Levers Health

LeanDose
Graded #167

Higher grade

vs+13.799999999999997
Levers Health
Graded #468

Lower grade

The verdict

LeanDose takes it — 67.1/100 to 53.3/100.

LeanDose grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LeanDose is a doctor-guided compounded GLP-1 telehealth service for eligible adults, with transparent all-inclusive first-month pricing: compounded semaglutide from $159 and tirzepatide from $279.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLeanDose +32
66
34
Dose & formulationLeanDose +10
64
54
Clinical oversightLeanDose +8
79
71
Labs & monitoringLeanDose +1
54
53
FulfillmentLeanDose +17
79
62
Contract termsEven
55
55
LeanDose · left barLevers Health · right bar

The numbers

MetricLeanDoseLevers Health
WeighScore67.1/10053.3/100
GradeCC
Scorecard rank#167#468
Semaglutide$159/mo (first-month rate, compounded)$247/mo (1.25 mg dose, compounded)
Tirzepatide$279/mo (first-month rate, compounded)$296/mo (5 mg dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
LeanDose

Graded #167 · C

Strengths

  • Transparent all-inclusive first-month pricing (compounded semaglutide from $159, tirzepatide from $279)
  • Verifiable LegitScript certification (seal ID 49840868) and an FDA-registered compounding pharmacy
  • Doctor-prescribed and supervised, with personalized care plans and multi-state clinical support
  • Convenient at-home delivery; compounded semaglutide and tirzepatide options
  • Honest, modest social proof — 119 five-star patient reviews

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Headline rates are first-month pricing; your ongoing monthly cost may be higher
  • Available in multiple states but the full list is not published on the homepage
  • The compounding pharmacy is FDA-registered but not named
Levers Health

Graded #468 · C

Strengths

  • Named LLC entity
  • Microdose GLP-1 option marketed for longevity
  • Both semaglutide and tirzepatide available

Where it loses points

  • No LegitScript or PCAB accreditation
  • No physical address disclosed
  • State availability not disclosed
  • FAQ and terms pages return 404
  • Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard